Ca2+ signaling in human fetoplacental vasculature: Effect of CGRP on umbilical vein smooth muscle cytosolic Ca2+ concentration

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 2 58-2, 2005, Pages

  Dong, Yuan Lin ^a   Vegiraju, Sujatha ^a   Yallampalli, Chandrasekhar ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Calcitonin gene related peptide; Cytosolic calcium mobilization; Fetoplacental circulation; Vascular smooth muscle cells

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATE; BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GLIBENCLAMIDE; IODINE 125; MESSENGER RNA; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; THAPSIGARGIN; UNCLASSIFIED DRUG; CALCIUM; ENZYME INHIBITOR;

ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; FETUS CIRCULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; THIRD TRIMESTER PREGNANCY; UMBILICAL VEIN; VASCULAR SMOOTH MUSCLE; VASODILATATION; BIOSYNTHESIS; BLOOD VESSEL; CELL LINE; CYTOSOL; DRUG EFFECT; EXTRACELLULAR FLUID; FEMALE; INTRACELLULAR MEMBRANE; METABOLISM; OSMOLARITY; PLACENTA CIRCULATION; PREGNANCY;

BLOOD VESSELS; BRADYKININ; CALCITONIN GENE-RELATED PEPTIDE; CALCIUM; CALCIUM SIGNALING; CELL LINE; CYCLIC AMP; CYTOSOL; ENZYME INHIBITORS; EXTRACELLULAR FLUID; FEMALE; HUMANS; INTRACELLULAR MEMBRANES; MUSCLE, SMOOTH, VASCULAR; OSMOLAR CONCENTRATION; PLACENTAL CIRCULATION; PREGNANCY; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; THAPSIGARGIN; UMBILICAL VEINS;

EID: 23744468858     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00059.2005     Document Type: Article

References (34)

1. Altura BM, Malaviya D, Reich CF, and Orkin LR. Effects of vasoactive agents on isolated human umbilical arteries and veins. Am J Physiol 222: 345-355, 1972.
2. Amara SG, Jonas V, Rosenfeld MG, Ong ES, and Evans RM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298: 240-244, 1982.
3. 2+ in aortic vascular smooth muscle cells. Can J Physiol Pharmacol 75: 652-660, 1997.
4. Bolton TB. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59: 606-718, 1979.
5. Brain SD, Williams TJ, Tippins HR, Morris JR, and MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 313: 54-56, 1985.
6. Carter AM and Myatt L. Control of placental blood flow: workshop report. Reprod Fertil Dev 7: 1401-1406, 1995.
7. Consigny PM. Vascular smooth muscle contraction and relaxation: pathways and chemical modulation. J Vasc Interv Radiol 2: 309-317, 1991.
8. Dong YL, Fang L, Kondapaka S, Gangula PR, Wimalawansa SJ, and Yallampalli C. Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy. J. Clin Invest 104: 559-565, 1999.
9. Dong YL, Gangula PRR, Fang L, Wimalawansa SJ, and Yallampalli C. Uterine relaxation responses to calcitonin gene-related peptide and calcitonin gene-related peptide receptors decreased during labor in rats. Am J Obstet Gynecol 179: 497-506, 1998.
10. Dong YL, Vegiraju S, Gangula PR, and Yallampalli C. Involvement of CGRP in control of human fetoplacental vascular tone. Am J Physiol Heart Circ Physiol 286: H230-H239, 2004.
11. Farley JR, Hall SL, and Herring S. Calcitonin acutely increases net 45Ca uptake and alters alkaline phosphatase specific activity in human osteosarcoma cells. Metabolism 42: 97-104, 1993.
12. Fukuizumi Y, Kobayashi S, Nishimura J, and Kanaide H. The effects of calcitonin gene-related peptide on the cytosolic calcium concentration and force in the porcine coronary artery. J Pharmacol Exp Ther 278: 220-231, 1996.
13. Gokhale SD, Gulati OD, Kelkar LV, and Kelkar VV. Effect of some drugs on human umbilical artery in vitro. Br J Pharmacol Chemother 27: 332-346, 1966.
14. 2+ dependence and physiological implication: Cell Calcium 21: 421-429, 1997.
15. Jeng YJ, Lolait SJ, Strakova Z, Chen C, Copland JA, Mellman D, Hellmich MR, and Soloff MS. Molecular cloning and functional characterization of the oxytocin receptor from a rat pancreatic cell line (RINm5F). Neuropeptides 30: 557-565, 1996.
16. 2+ concentrations in UMR 106 osteoblastic cells. Bone 16: 379S-384S, 1995.
17. Kimura M, Kimura I, and Kobayashi S. Relationship between cyclic AMP-dependent protein kinase activation and Ca uptake increase of sarcoplasmic reticulum fraction of hog biliary muscles relaxed by cholecystokinin-C-terminal peptides. Biochem Pharmacol 31: 3077-3083, 1982.
18. 2+ release in smooth muscle. Physiological role of inositol 1,4,5-trisphosphate in pharmacomechanical coupling. J Biol Chem 264: 17997-18004, 1989.
19. Kubota M, Moseley JM, Butera L, Dusting GJ, MacDonald PS, and Martin TJ. CGRP stimulates cAMP formation in rat aortic smooth muscle cells. Biochem Biophys Res Commun 132: 88-94, 1985.
20. Laufer R and Changeux JP. Calcitonin gene-related peptide and cyclic AMP stimulate phosphoinositide turnover in skeletal muscle cells. Interaction between two second messenger systems. J Biol Chem 264: 2683-2689, 1989.
21. Marceau F, Levesque L, Drapeau G, Rioux F, Salvino JM, Wolfe HR, Seoane PR, and Sawutz DG. Effects of peptide and nonpeptide antagonists of bradykinin B2 receptors on the venoconstrictor action of bradykinin. J Pharmacol Exp Ther 269: 1136-1143, 1994.
22. + channels. Nature 344: 770-773, 1990.
23. Njuki F, Nicholl CG, Howard A, Maks JC, Barnes PJ, Girgis SI, and Legon S. A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin Sci (Lond) 85: 385-388, 1993.
24. Ozaki H, Sato K, Satoh T, and Karaki H. Simultaneous recordings of calcium signals and mechanical activity using fluorescent dye fura 2 in isolated strips of vascular smooth muscle. Jpn J Pharmacol 45: 429-433, 1987.
25. Parida SK, Schneder DB, Stoss TD, Pauly TH, and McGillis JP. Elevated circulating calcitonin gene-related peptide in umbilical cord and infant blood associated with maternal and neonatal sepsis and shock. Pediatr Res 43: 276-282, 1998.
26. Parsons AM and Seybold VS. Calcitonin gene-related peptide induces the formation of second messengers in primary cultures of neonatal rat spinal cord. Synapse 26: 235-242, 1997.
27. 2+ response to bradykinin in different types of juxtamedullary glomerular arterioles. Am J Physiol Renal Physiol 277: F697-F705, 1999.
28. 2+ pump of bovine pulmonary artery. Cell Calcium 11: 261-268, 1990.
29. Roh J, Chang CL, Bhalla A, Klein C, and Hsu SYT. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 279: 7264-7274, 2004.
30. + channels in arterial smooth muscle. Science 245: 177-180, 1989.
31. Stevenson JC, MacDonald DWR, Warren RC, Booker MW, and Whitehead MI. Increased concentration of circulating calcitonin gene-related peptide during normal human pregnancy. Br Med J 293: 1329-1330, 1986.
32. Viswanathan M. Melatonin inhibits calcitonin gene-related peptide-induced vasodilation and increase in cAMP in rat middle cerebral arteries. Eur J Pharmacol 415: 247-250, 2001.
33. Wimalawansa SJ. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology and therapeutic potentials. Endocr Rev 17: 533-585, 1996.
34. 2+ release from skinned rat aortic smooth muscle cells in primary cutlure. Naunyn Schmiedebergs Arch Pharmacol 341: 273-278, 1990.